Table 2 Antimicrobial susceptibility result for 101 E. coli urinary tract isolates in study period from January to March 2008
Antibiotic name | Number of isolates n (%) classified as | |||||
|---|---|---|---|---|---|---|
Pediatric (n = 29 isolates) | Adult (n = 50 isolates) | Elderly (n = 22 isolates) | ||||
Sensitive | Resistance | Sensitive | Resistance | Sensitive | Resistance | |
Ampicillin | 5 (17.24%) | 24 (82.76%) | 21 (42%) | 29 (58%) | 8 (36.36%) | 14 (63.64%) |
Augmentin | 26 (89.66%) | 3 (10.34%) | 45 (90%) | 5 (10%) | 16 (72.73%) | 6 (27.27%) |
Co-trimoxazole | 14 (48.28%) | 15 (51.72%) | 29 (58%) | 21 (42%) | 9 (40.91%) | 13 (59.09%) |
Ciprofloxacin | 27 (93.1%) | 1 (3.44%) | 46 (92%) | 4 (8%) | 16 (72.73%) | 6 (27.27%) |
Nitrofurantoin | 29 (100%) | 0 (0.00%) | 49 (98%) | 1 (2%) | 20 (90.91%) | 2 (9.09%) |
Cefazolin | 25 (86.21%) | 4 (13.79%) | 43 (86%) | 7 (14%) | 15 (68.18%) | 7 (31.82%) |